NDC 42291-103-90 - AcetaZOLAMIDE
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 42291-103
- Requested NDC
- 42291-103-90
- Package NDCs from labels
- 42291-103-10, 42291-103-90
- Manufacturer
- AvKARE
- Effective date
- 2022-01-13
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| AcetaZOLAMIDE - AvKARE | AvKARE | 2022-01-13 | HUMAN PRESCRIPTION DRUG LABEL |
| National Council for Prescription Drug Programs indexing - billing unit | National Council for Prescription Drug Programs | 2013-02-13 | Indexing - Billing Unit |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 42291-103-10 | EA - Each | 42291-103 | a522cfff-4fd9-43c1-babc-b9b72cc9bde7 | 1 | 2013-12-02 |
| 42291-103-90 | EA - Each | 42291-103 | 8f6f5e42-45c2-4397-858e-19d280705eec | 1 | 2013-02-13 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| ACETAZOLAMIDE | ACTIVE INGREDIENT | O3FX965V0I | ACETAZOLAMIDE (ACETAZOLAMIDE) TABLET [AVKARE, INC.] | 3 | |
| ACETAZOLAMIDE | ACTIVE MOIETY | O3FX965V0I | ACETAZOLAMIDE (ACETAZOLAMIDE) TABLET [AVKARE, INC.] | 3 | |
| CALCIUM STEARATE | INACTIVE INGREDIENT | 776XM7047L | ACETAZOLAMIDE (ACETAZOLAMIDE) TABLET [AVKARE, INC.] | 3 | |
| LACTOSE MONOHYDRATE | INACTIVE INGREDIENT | EWQ57Q8I5X | ACETAZOLAMIDE (ACETAZOLAMIDE) TABLET [AVKARE, INC.] | 3 | |
| SODIUM STARCH GLYCOLATE TYPE A POTATO | INACTIVE INGREDIENT | 5856J3G2A2 | ACETAZOLAMIDE (ACETAZOLAMIDE) TABLET [AVKARE, INC.] | 3 | |
| STARCH, CORN | INACTIVE INGREDIENT | O8232NY3SJ | ACETAZOLAMIDE (ACETAZOLAMIDE) TABLET [AVKARE, INC.] | 3 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Acetazolamide | ACETAZOLAMIDE | Strides Pharma Science Limited | 4813b9dd-5f58-44bb-ad64-cdb331828080 | 2026-08-19 | Warnings, Adverse reactions | O3FX965V0I |
| Acetazolamide | ACETAZOLAMIDE | PD-Rx Pharmaceuticals, Inc. | 268db224-d5db-457c-86bc-972c9fe07917 | 2026-07-07 | Warnings, Adverse reactions | O3FX965V0I |
| acetazolamide | ACETAZOLAMIDE | Major Pharmaceuticals | 37135ba5-63fd-427f-9b4a-8b7d1009bbca | 2026-05-28 | Warnings, Adverse reactions | O3FX965V0I |
| Acetazolamide | ACETAZOLAMIDE | A-S Medication Solutions | c5acf531-ba55-47b7-88db-e5da0206ebf1 | 2026-05-22 | Warnings, Adverse reactions | O3FX965V0I |
| Acetazolamide | ACETAZOLAMIDE | Bryant Ranch Prepack | 71f1fbbb-428e-4bf7-bc20-2946c1079bd3 | 2026-05-20 | Warnings, Adverse reactions | O3FX965V0I |
| acetazolamide | ACETAZOLAMIDE | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 0700a910-79aa-4431-aecf-637fe14fcae8 | 2026-05-12 | Warnings, Adverse reactions | O3FX965V0I |
| acetazolamide | ACETAZOLAMIDE | A-S Medication Solutions | 07fd0bde-8f7c-47d2-9e81-2c1eee259fa6 | 2026-05-01 | Warnings, Adverse reactions | O3FX965V0I |
| Acetazolamide | ACETAZOLAMIDE | REMEDYREPACK INC. | fb2cf8fe-da81-445e-a18b-9aa9ced1d34a | 2026-04-28 | Warnings, Adverse reactions | O3FX965V0I |
| Caldesene Baby | STARCH, CORN AND ZINC OXIDE | Insight Pharmaceuticals LLC | 9f12dee2-7afa-45e9-a729-0fd42bb77715 | 2026-04-22 | Warnings | O8232NY3SJ |
| Caldesene Medicated Protecting | CORNSTARCH AND ZINC OXIDE | Insight Pharmaceuticals LLC | ffc92a0f-a7cf-4a46-b2f1-089df2bbb96b | 2026-04-22 | Warnings | O8232NY3SJ |
| acetazolamide | ACETAZOLAMIDE | Bryant Ranch Prepack | 0d903375-c583-4362-9f8a-f7b74ce01e0b | 2026-04-09 | Warnings, Adverse reactions | O3FX965V0I |
| Acetazolamide | ACETAZOLAMIDE | Bryant Ranch Prepack | 9af15152-d46f-4bc3-a16e-b70a472bc52a | 2026-03-23 | Warnings, Adverse reactions | O3FX965V0I |
| Acetazolamide | ACETAZOLAMIDE | Bryant Ranch Prepack | 84a582a9-c7e5-4159-a5eb-a47a96b4afc0 | 2026-03-23 | Warnings, Adverse reactions | O3FX965V0I |
| Acetazolamide | ACETAZOLAMIDE | Bryant Ranch Prepack | f7227cc5-0a80-47df-baf8-09f1b22b187e | 2026-03-20 | Warnings, Adverse reactions | O3FX965V0I |
| Acetazolamide | ACETAZOLAMIDE | Lifestar Pharma LLC | 0913db35-3f08-4d82-8394-486bd9a487c4 | 2026-03-17 | Warnings, Adverse reactions | O3FX965V0I |
| Acetazolamide | ACETAZOLAMIDE | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 33d912ea-9e1c-49eb-bd93-f0b1b2da67b6 | 2026-02-26 | Warnings, Adverse reactions | O3FX965V0I |
| acetazolamide | ACETAZOLAMIDE | AvKARE | d6fba129-ac6e-4d04-bd09-8470be4e7ecc | 2026-02-24 | Warnings, Adverse reactions | O3FX965V0I |
| Acetazolamide | ACETAZOLAMIDE | Westminster Pharmaceuticals, LLC | 417b1df2-63bc-473c-9e02-5f93dd45554d | 2026-02-17 | Warnings, Adverse reactions | O3FX965V0I |
| acetaZOLAMIDE | ACETAZOLAMIDE | A-S Medication Solutions | b339843f-0324-4996-88a0-0619fd6f867b | 2026-02-13 | Warnings, Adverse reactions | O3FX965V0I |
| Acetazolamide | ACETAZOLAMIDE | Marlex Pharmaceuticals, Inc. | 4a03f35d-bfcb-77ff-e063-6294a90a4f06 | 2026-02-01 | Warnings, Adverse reactions | O3FX965V0I |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.